Effect of Dexmedetomidine on Pacemaker Function Following Cardiac Surgery

Withdrawn before enrolling

Conditions studied: Congenital Heart Disease

In brief

This is a prospective study looking at the effects of dexmedetomidine on pacemaker function in patients who have surgery for congenital heart disease utilizing cardiopulmonary bypass (CBP). For the purpose of the study, no change in intraoperative care will be dictated. The use of dexmedetomidine will be left up to the discretion of the treating physicians. The study will involve only the collection of data regarding the amplitude required to capture and specific demographics and intraoperative features including cross clamp time, time on CPB, and vasoactive agents that were and are being administered. In addition to these data, it will be noted whether dexmedetomdine was used or not and whether it is being administered on arrival to the CTICU.

Key facts

Study ID

NCT02709200

Run by

Nationwide Children's Hospital

People needed

0

Starts

2016-02-01

Expected to finish

2019-03-11

Last updated by the study team

2019-03-28

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with temporary surface pacemaker leads following surgery for congenital heart disease.

You may not qualify if…

• Patients with single ventricle anatomy
• Patients receiving epinephrine
• Infants less than 6 months of age

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.